Maintenance therapy after quadruple induction therapy in HIV-1 infected individuals: Amsterdam Duration of Antiretroviral Medication (ADAM) study
MHE Reijers, GJ Weverling, S Jurriaans, FWNM Wit… - The Lancet, 1998 - thelancet.com
Background Highly active antiretroviral therapy (HAART) has led to health benefits for
patients infected with HIV-1. However, long-term use of multidrug regimens is difficult to …
patients infected with HIV-1. However, long-term use of multidrug regimens is difficult to …
Maintenance therapy after quadruple induction therapy in HIV-1 infected individuals: Amsterdam Duration of Antiretroviral Medication (ADAM) study
MH Reijers, GJ Weverling, S Jurriaans… - …, 1998 - researchinformation.amsterdamumc …
BACKGROUND: Highly active antiretroviral therapy (HAART) has led to health benefits for
patients infected with HIV-1. However, long-term use of multidrug regimens is difficult to …
patients infected with HIV-1. However, long-term use of multidrug regimens is difficult to …
Maintenance therapy after quadruple induction therapy in HIV-1 infected individuals: Amsterdam Duration of Antiretroviral Medication (ADAM) study.
MH Reijers, GJ Weverling, S Jurriaans… - Lancet (London …, 1998 - europepmc.org
Background Highly active antiretroviral therapy (HAART) has led to health benefits for
patients infected with HIV-1. However, long-term use of multidrug regimens is difficult to …
patients infected with HIV-1. However, long-term use of multidrug regimens is difficult to …
[引用][C] Maintenance therapy after quadruple induction therapy in HIV-1 infected individuals: Amsterdam Duration of Antiretroviral Medication (ADAM) study
MHE REIJERS, GJ WEVERLING… - Lancet (British …, 1998 - pascal-francis.inist.fr
Maintenance therapy after quadruple induction therapy in HIV-1 infected individuals: Amsterdam
Duration of Antiretroviral Medication (ADAM) study CNRS Inist Pascal-Francis CNRS Pascal and …
Duration of Antiretroviral Medication (ADAM) study CNRS Inist Pascal-Francis CNRS Pascal and …
Maintenance therapy after quadruple induction therapy in HIV-1 infected individuals: Amsterdam Duration of Antiretroviral Medication (ADAM) study
MHE Reijers, GJ Weverling, S Jurriaans, FWNM Wit… - The Lancet, 1998 - thelancet.com
Background Highly active antiretroviral therapy (HAART) has led to health benefits for
patients infected with HIV-1. However, long-term use of multidrug regimens is difficult to …
patients infected with HIV-1. However, long-term use of multidrug regimens is difficult to …
Maintenance therapy after quadruple induction therapy in HIV-1 infected individuals: Amsterdam Duration of Antiretroviral Medication (ADAM) study
MHE Reijers, GJ Weverling, S Jurriaans, FWNM Wit… - The Lancet, 1998 - Elsevier
BACKGROUND: Highly active antiretroviral therapy (HAART) has led to health benefits for
patients infected with HIV-1. However, long-term use of multidrug regimens is difficult to …
patients infected with HIV-1. However, long-term use of multidrug regimens is difficult to …
Maintenance therapy after quadruple induction therapy in HIV-1 infected individuals: Amsterdam Duration of Antiretroviral Medication (ADAM) study
MHE Reijers, GJ Weverling, S Jurriaans, FWNM Wit… - The Lancet, 1998 - infona.pl
Highly active antiretroviral therapy (HAART) has led to health benefits for patients infected
with HIV-1. However, long-term use of multidrug regimens is difficult to sustain. Simplifying …
with HIV-1. However, long-term use of multidrug regimens is difficult to sustain. Simplifying …
Maintenance therapy after quadruple induction therapy in HIV-1 infected individuals: Amsterdam Duration of Antiretroviral Medication (ADAM) study.
MHE Reijers, GJ Weverling - The Lancet, 1998 - elibrary.ru
Looks at highly active antiretroviral therapy's (HAART) health benefits to patients infected
with HIV-1. Difficulty of maintaining long-term use of multidrug regimens; How simplifying …
with HIV-1. Difficulty of maintaining long-term use of multidrug regimens; How simplifying …
Maintenance therapy after quadruple induction therapy in HIV-1 infected individuals: Amsterdam Duration of Antiretroviral Medication (ADAM) study.
MHE Reijers, GJ Weverling, S Jurriaans, F Wit… - 1998 - cabidigitallibrary.org
From March, 1997, patients were enrolled who were infected with HIV-1 with at least 200
CD4+ cells/µL, at least 1000 HIV-1 RNA copies/mL in plasma, and no previous exposure to …
CD4+ cells/µL, at least 1000 HIV-1 RNA copies/mL in plasma, and no previous exposure to …
Maintenance therapy after quadruple induction therapy in HIV-1 infected individuals: Amsterdam Duration of Antiretroviral Medication (ADAM) study
MH Reijers, GJ Weverling… - Lancet (London …, 1998 - pubmed.ncbi.nlm.nih.gov
Background Highly active antiretroviral therapy (HAART) has led to health benefits for
patients infected with HIV-1. However, long-term use of multidrug regimens is difficult to …
patients infected with HIV-1. However, long-term use of multidrug regimens is difficult to …